Olaparib halts tumour growth in advanced prostate cancer Olaparib, a drug approved for the treatment of women with ovarian cancer who have inherited BRCA mutations, also benefits men with prostate cancer.…
Melanoma therapy that targets PD-1 recommended for EU approvalThe European Medicines Agency has recommended granting a marketing authorisation for new melanoma treatment nivolumab.…
New therapy to tackle treatment-resistant cancers Scientists have developed a therapy that could outsmart cancer cells that have become immune to certain treatments, according to a study published in Cancer Cell.…
UK political parties discuss healthcare and pharmacy issues ahead of general election Ahead of the UK public going to the polls on 7 May in the 2015 general election, the three largest political parties in Westminster respond to questions on the big issues in healthcare and pharmacy.…
Small molecule could pave way for novel vaccine adjuvants Identification and characterisation of a small molecule that targets protein receptors that stimulate the immune system could lead to novel vaccine adjuvants and anti-tumour agents.…
Imatinib mimics physiological response to produce antimicrobial effectsThe anti-cancer agent imatinib at very low doses mimics a physiological innate response to infection in the bone marrow, research shows.…
Researchers create personalised vaccines for patients with advanced melanoma A study has revealed that targeting patient-specific markers in advanced melanoma tumours effectively triggers an immune response.…
Tetanus injection boosts immune response, researchers find Researchers have induced a stronger immune response to dendritic cell therapy in patients with glioblastoma using injections of tetanus and diphtheria toxins.…
EMA fast tracks approval of thyroid cancer drugThe European Medicines Agency is recommending that Lenvima (lenvatinib) be available across Europe for the treatment of some patients with thyroid cancer.…
HPV vaccine Gardasil 9 is approved by European drug regulatorA human papillomavirus vaccine that protects against nine different strains of the virus has been given preliminary approval by the European Medicines Agency.…